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Background: The current literature reports increased infectious disease occurrence in various construction
occupations, as an important contributor to morbidity and mortality arising from employment.
These observations should be expanded to asbestos abatement workers, as the abatement can create an
environment favorable for bacterial, viral and fungal infections.
Discussion: Asbestos abatement work employs activities resulting in cuts, blisters and abrasions to the skin, work in
a dirty environment and exposure to dust, mists and fumes.
Furthermore, this population exhibits a high smoking rate which increases the risk of chronic obstructive pulmonary
disease and respiratory infections.
In addition, these workers also commonly employ respirators, which can accumulate dirt and debris magnifying
exposure to microbes. Use of respirators and related types of personal protective equipment, especially if shared
and in the close environment experienced by workers, may enhance communicability of these agents,
including viruses.
Summary: Abatement workers need to be provided with information on hazards and targeted by appropriate
health education to reduce the infection risk. Epidemiological studies to investigate this risk in asbestos removers
are recommended.Background
Several studies [1-5] have reported on increased infec-
tious disease occurrence in various construction occupa-
tions, with these agents constituting an important
contributor to morbidity and mortality arising from
employment.
We believe these observations need to be expanded to
asbestos abatement workers, especially since infectious
diseases appear to be associated with certain industrial
occupations, most notably those in the construction
industry.
Respiratory diseases are commonly discussed as a
hazard for those employed in the asbestos abatement
industry, although focus is on cancer and asbestosis.
Recently there has even been a suggestion of exposure
to asbestos contributing to cardiovascular disease [6]* Correspondence: l.cegolon@gmail.com
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reproduction in any medium, provided the orwith this agent causing disease states in locations other
than the lungs and those traditionally identified, espe-
cially at high exposure levels [7]. For this group of
workers there are periodically discussions of other
non-asbestos hazards (e.g. confined conditions, heat
disorders, etc.), with the literature rarely mentioning
infectious diseases [8,9].Discussion
One study [1] reported exposure to inorganic dust, which
includes asbestos, for construction workers resulted in a
high rate of mortality from infectious pneumonia (relative
risk for inorganic dust =1.87, with 95% confidence interval:
1.22-2.89). Since asbestos abatement workers are exposed
to both inorganic/mineral dusts and chemicals, it would
appear a risk from infectious disease exists and include
various forms of infections (e.g. skin) beside mortality from
pneumonia as indicated by Thoren [1] for inorganic dust.
A PubMed search of “asbestos abatement and infectious
disease”, “asbestos abatement and infections”, “asbestos
workers and infectious disease” or “asbestos workers andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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existed as related to fungal exposure during abatement
[10]. Today, mold (fungal) exposure during abatement is
recognized as a hazard for this type of industry [11,12].
Overall, abatement can create an environment favor-
able for bacterial and fungal infections [13]. For con-
struction workers, most reports discuss infections
related to bacterial or fungal diseases [3,13,14], but have
not clearly illustrated how this hazard extends to
asbestos-related work. This report may be the first in
the open literature expressing the concept of infectious
disease risk directly linked to asbestos abatement
workers.
Asbestos abatement work employs activities resulting
in cuts, blisters and abrasions to the skin, work in a
dirty environment and exposure to dust, mists and
fumes (i.e. inorganic and mineral dusts). Exposures and
operations of this nature place this group (abatement
workers in general) at risk for skin and mucous mem-
brane, uro-genital tract, respiratory, gastro-intestinal
tract, cutaneous, direct contact, animal reservoirs-
related and inanimate grouped infections as classified
by Haagsma [2]. Infection risk in construction as well
as in asbestos abatement work should probably be con-
sidered similar to other industries’ that a lay person
may consider riskier in terms of communicable diseases
(e.g. underground mining [15-17], agriculture [18,19],
cattle farming [20], sewerage work [21-24], infantry in
military [25], etc.).
Furthermore, asbestos abatement workers exhibit a
high smoking rate (e.g. 70%) [26], which increases the
risk of chronic obstructive pulmonary disease (COPD)
and respiratory infections. It has also been observed that
even non-smokers exposed to inorganic dust have an
increased mortality rate for COPD [27], enhancing the
potential of infection.
In addition, these workers also commonly employ
respirators, which can accumulate dirt and debris magni-
fying exposure to microbes. Use of respirators and
related types of personal protective equipment, especially
if shared and in the close environment experienced by
workers, may enhance communicability of these agents,
including viruses. Moreover dermatitis from various
causes (e.g. chemical and infectious agents) is a concern
[28].
With these findings, type of work performed by abate-
ment workers and their high rate of smoking, it appears
this occupational group is at increased risk for various
types of infectious disease, including those associated
with the pulmonary system.
This hazard may be of even greater importance for as-
bestos abatement workers in terms of health conse-
quences (e.g. emerging as an important risk factor) since
current exposure to asbestos has been shown to be lowand there is now little risk of asbestos-related disease for
this population (asbestos abatement workers – in the
western world) [29,30].
When discussing non-asbestos disease hazards for this
occupational population, infectious (microbial) agents
should be included along with hygiene practices related
to prevention. Abatement workers need to be provided
with information on hazards and prevention of infec-
tious disease and dermatitis; the Internet can be a very
helpful resource in this complex and changing field if
used efficiently [31]. Personnel also need to be targeted
by health education aimed at reducing the infection risk
[32]. Decontamination and hand washing would appear
to be of great importance, but is not the only form of
protection/prevention available (e.g. disinfection agents),
especially for dermatological and gastro-intestinal risks/
hazards. Abatement workers have routine physical
examinations primarily focusing on the pulmonary sys-
tem and the ability to use a respirator. However, in many
cases this has become a bureaucratic paper process act-
ing as a work permit and not functioning as a true
evaluation of health [33]. Regardless, it may be prudent
during this evaluation also to check these workers for
their current level of vaccination (e.g. against Pneumo-
coccus, Haemophilus influenza type b and tetanus tox-
oid), and according to the type and location of work
other vaccines could be considered, where appropriate
and feasible [34]. In many ways, this is a forgotten aspect
of occupational medicine, especially for those undertak-
ing various forms of abatement. A major role can be
played by general practitioners and occupational physi-
cians in terms of health education. These preventive
measures can be applied to the construction-related in-
dustries in general.Summary
The underestimation of the infectious risk among asbes-
tos removers is likely due to the limited number of epi-
demiological studies on asbestos abatement workers as
compared to asbestos workers.
Indeed, as they are exposed to both inorganic/mineral
dusts and chemicals, these workers would appear at
risk from various forms of infections and communic-
able diseases. Therefore an evaluation of this population
regarding infectious disease occurrence seems to be re-
commended to determine the extent of this hazard as
suggested more broadly by Haagsma [2]. Lastly, abate-
ment workers need to be provided with information on
hazards and targeted by appropriate health education to
reduce the infection risk.Competing interests
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